Linqi Yang
Shijiazhuang, 050200, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.
Journal: International journal of biological sciences
Published: July 07, 2023
DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
Journal: Disease markers
Published: April 19, 2022
Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Journal: Frontiers in genetics
Published: September 25, 2021
The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Journal: Disease markers
Published: April 26, 2021
Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).
Journal: Disease markers
Published: April 11, 2021
CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1.
Journal: International journal of biological sciences
Published: September 24, 2020
6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells.
Journal: Disease markers
Published: December 31, 2019
The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
Journal: Current drug targets
Published: November 01, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026